ArticleBMC medical informatics and decision making2025
Risk assessment and prediction of early blood transfusion after joint replacement surgery: a clinical decision support model based on machine learning.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Artificial Intelligence in Arthroplasty: A Comprehensive Structured Critical Review and Descriptive Evidence Map of Validation, Uncertainty, and Workflow Integration.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPostoperative blood transfusion remains a major challenge in joint arthroplasty, with substantial variability in clinical decision-making. Therefore, this study aimed to develop and validate machine learning models for early postoperative transfusion risk assessment to support early postoperative decision-making, with the clinical objective of minimizing unnecessary transfusions and improving perioperative blood resource utilization after joint arthroplasty.
methodsWe retrospectively analyzed 1,954 patients who underwent primary or revision hip or knee arthroplasty between June 2019 and December 2024. Patients were categorized according to whether they received allogeneic transfusion within 72 h postoperatively. The dataset was randomly divided into training (70%) and validation (30%) cohorts. Logistic regression (LR), random forest (RF), and support vector machine (SVM) models were developed based on 15 key variables identified through LASSO regression. Model discrimination, calibration, and clinical utility were evaluated using ROC curves, Hosmer–Lemeshow tests, Brier scores, calibration slopes/intercepts, and decision curve analysis (DCA). SHAP analysis was used to interpret variable importance.
resultsAmong all patients, 172 (8.8%) received transfusions. All three models showed good discrimination (AUC > 0.75). The RF model achieved the best overall performance (training AUC = 1.000; validation AUC = 0.808, sensitivity = 87.5%, specificity = 59.0%; Brier score = 0.0651). The LR model also demonstrated stable calibration (Hosmer–Lemeshow p = 0.097, Brier = 0.0679), while the SVM model achieved moderate discrimination (validation AUC = 0.776) but weaker calibration. DCA confirmed that the RF model provided the greatest net clinical benefit within a threshold range of 0.1–0.75. SHAP analysis of RF model showed that postoperative hemoglobin, preoperative hemoglobin and operation time were the most important predictors.
conclusionPostoperative and preoperative haemoglobin levels, along with operative duration, were important predictors of early postoperative transfusion. The RF model demonstrated good predictive performance and clinical value, supporting its potential use for individualized transfusion risk assessment in patients undergoing joint arthroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.